antipsychotic medications presently used clinically were not designed to target altered
GABAergic or glutamatergic neurotransmission.
NIH-PA Author Manuscript
NIH-PA Author Manuscript
NIH-PA Author ManuscriptA primary objective of our studies has been to understand more about the specificintracellular signal transduction processes and nuclear events involved in thepharmacological action of antipsychotics by testing whether antipsychotic drugs elicitfunctionally relevant neuroepigenetic changes at GABAergic and glutamatergic genepromoters.Understanding more about the action of antipsychotic drugs on neuroepigenetic mechanismswill not only accelerate the development of novel pharmacological agents to treat SZ and BPdisorder but should also provide insights into the underlying neurobiological causes of thesedisorders.The reciprocal interaction between GABAergic interneurons andglutamatergic pyramidal principal neurons is altered in the cortex orhippocampus of SZ or BP disorder patientsWhen the postmortem brain of SZ and BP disorder patients is compared to that of non-psychiatric subjects, GABAergic neuropathology is detected in the hippocampus and cortex(Akbarian et al., 1995; Benes et al., 1992; Benes and Berretta, 2001, Fatemi et al., 2000,Guidotti et al., 2000; 2005, Impagnatiello et al., 1998; Lewis et al., 2005; Veldic et al.,2007). The GABAergic neuropathology found in the brain of SZ and BP disorder patients ischaracterized by a decrease in the expression of glutamic acid decarboxylase67 (GAD67).
GABAergic pathology is also characterized by decreased expression of nicotine
acetylcholine receptor (nAChR) α4 and α7 subunits (Breese et al., 2000) and by a decrease
in other proteins abundantly expressed in GABAergic neurons, such as the NMDA receptor
subunit NR2A and the kainate receptor subunit GluR5 (Bitanihirwe et al., 2009; Woo et al.,
2004, 2008). Further, there are decreases in somatostatin, tyrosine kinase B (TrkB)
receptors, cholecystokinin, GABA transporter-1, parvalbumin (Lewis et al., 2005), and
reelin (for a review see Guidotti et al., 2005).
Reelin is a large (400 kDa) extracellular matrix protein that is most abundantly synthesized
in GABAergic neurons of cortical layers I and II, and in the hippocampus, caudate, and
putamen (Guidotti et al. 2000,Costa et al., 2001, Veldic et al. 2007, Guidotti et al., 2009,
Levenson et al., 2008). In the cortex, upon secretion reelin adheres to postsynaptic densities
located on dendritic spines and shafts of pyramidal neurons (Costa et al., 2001). This protein
binds to specific receptors [apolipoprotein E 2 (ApoE2), very low density lipoprotein
(VLDL), and integrin], harmonizing local dendritic protein synthesis rates necessary for: 1)
dendritic spine formation, 2) spine maturation, and 3) the regulation of glutamate receptor
structure and function (Costa et al., 2001; Guidotti et al., 2009, Levenson et al., 2008,
Pujadas et al., 2010; Tueting et al., 1999, 2010). It is important to note that a decrease of
GAD67 and reelin expression in brain of SZ or BP disorder patients has not been always
confirmed. For example in one study an increase instead of a decrease of GAD67 was
reported (Dracheva et al. 2004) and in another study lack of a significant decrease of reelin
DNA methylation and demethylation神经疾病靶点_生物学_自然科学_专业资料。Pharmacological...Epigenetic GABAergic targets in schizophrenia and bipolar disorder. Neuroph...
et al.Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Hum Mol Genet. 2011; 20: 4786-4796. Rogd...
et al.Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Hum Mol Genet. 2011; 20: 4786-4796. Rogd...
热门文档